Cite
HARVARD Citation
Tageja, N. et al. (2018). Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma. Bone marrow transplantation. pp. 1445-1449. [Online].